SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AstraZeneca Q3 Revenue Rises 7% on Oncology Strength

AstraZeneca reported a 7% increase in Q3 revenue, citing strength in its Oncology unit.

AZN

Related stories